These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6602896)

  • 1. [T and B cells and ADCC (antibody-dependent cell-mediated cytotoxicity) in Sjogren's disease].
    Arimori S; Ichikawa Y; Takaya M
    Nihon Rinsho; 1983; 41(2):446-9. PubMed ID: 6602896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphocyte cytotoxicity actions (antibody-dependent cell-mediated cytotoxicity and NK function) in Sjogren's disease].
    Shigehara T; Goto M; Takeuchi A; Hashimoto A; Tanimoto K
    Nihon Rinsho; 1983; 41(2):449-51. PubMed ID: 6865015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on killer cells (K-cells) in peripheral blood in Sjögren's syndrome (author's transl)].
    Ichikawa Y; Sasao K; Takaya M; Arimori S
    Ryumachi; 1980 Sep; 20(4):253-9. PubMed ID: 7444663
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody-dependent cell-mediated cytotoxicity by peripheral blood mononuclear cells from patients with Sjögren's syndrome, with special reference to differentiation from phagocytic activity.
    Ichikawa Y; Takaya M; Arimori S
    Tokai J Exp Clin Med; 1980 Jan; 5(1):83-90. PubMed ID: 7385266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ADCC (antibody-dependent cell-mediated cytotoxicity) in Sjogren's disease].
    Suzuki T; Imai F; Ishibashi T; Sekiya S
    Nihon Rinsho; 1983; 41(2):444-6. PubMed ID: 6865014
    [No Abstract]   [Full Text] [Related]  

  • 6. [Etiopathogenic aspects of Sjögren's syndrome].
    Palomino Nicas J; Villar Ortiz J; Viciana Fernández P; Piedra Priego J; Carneado de la Fuente J
    Rev Clin Esp; 1984 Jun 15-30; 173(5-6):253-8. PubMed ID: 6387825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sjogren's syndrome and Sjogren's disease in rheumatology].
    Nasonova V; Vasiljev V
    Z Gesamte Inn Med; 1981 Mar; 36(6):199-203. PubMed ID: 6973248
    [No Abstract]   [Full Text] [Related]  

  • 8. [Natural cytotoxicity in Sjögren's syndrome].
    Aleksandrova EN; Nasonov EL; Vasil'ev VI; Bykhovskaia SIu; Zimin IuI
    Ter Arkh; 1984; 56(7):103-6. PubMed ID: 6484820
    [No Abstract]   [Full Text] [Related]  

  • 9. [Variants in the course of Sjögren's disease].
    Vasil'ev VI; Kadagidze ZG; Simonova MV; Veskova TK; Iudina IuV
    Ter Arkh; 1982; 54(6):41-9. PubMed ID: 6981223
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathogenesis of Sjögren's syndrome.
    Moutsopoulos HM
    Isr J Med Sci; 1988 Dec; 24(12):737-9. PubMed ID: 3066783
    [No Abstract]   [Full Text] [Related]  

  • 12. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome.
    Skopouli FN; Fox PC; Galanopoulou V; Atkinson JC; Jaffe ES; Moutsopoulos HM
    J Rheumatol; 1991 Feb; 18(2):210-4. PubMed ID: 1827160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens.
    Fox RI; Hugli TE; Lanier LL; Morgan EL; Howell F
    J Immunol; 1985 Jul; 135(1):207-14. PubMed ID: 3923102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An increase in peripheral blood Ia-positive T cells in Sjögren's syndrome correlates with a decrease in the autologous mixed lymphocyte response.
    Sauvezie B; Miyasaka N; Charron D; Kielich C; Loeb J; Daniels TE; Talal N
    Clin Exp Immunol; 1982 Jul; 49(1):50-8. PubMed ID: 6215195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
    Pedersen BK; Oxholm P; Manthorpe R; Andersen V
    Clin Exp Immunol; 1986 Jan; 63(1):1-7. PubMed ID: 3485480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the immune status in patients with primary and secondary Sjögren's syndrome.
    Slezák R; Krejsek J; Kopecký O; Drízhal I
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(1):11-2. PubMed ID: 7569721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating immune complexes and cellular cytotoxic reactions in Sjögren's syndrome].
    Nasonov EL; Vasil'ev VI; Aleksandrova EN; Nasonova SV; Timofeeva EB
    Ter Arkh; 1988; 60(4):13-6. PubMed ID: 2969150
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of the phenotype and function of lymphocytes infiltrating the salivary gland in patients with primary Sjogren syndrome.
    Fox RI; Adamson TC; Fong S; Young C; Howell FV
    Diagn Immunol; 1983; 1(3):233-9. PubMed ID: 6238753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody-dependent and natural cellular cytotoxic reactions in rheumatic diseases].
    Aleksandrova EN; Zimin IuI; Nasonov EL
    Ter Arkh; 1984; 56(10):130-6. PubMed ID: 6084315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preliminary study on the activity of natural killer cells in patients with Sjogren's syndrome].
    Wang JM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1988 Jul; 23(4):244-6. PubMed ID: 3234131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.